To see the usefulness of the newly formed repertory based on Indian Homoeopathic Drugs

To form a repertory on Indian Homoeopathic Drugs from Boericke Materia Medica and Homoeopathic Materia Medica of Indian Drugs by CCRH and its clinical verification. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084135

Enrollment

Registered

2025-04-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

Intervention1: 73- Indian Homoeopathic Drugs: 6C, 30C, 200C, 1M potency Repetition- Depending upon the need of the case Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: - The cases in which totality of symptoms will match with the Indian homoeopathic drugs will be included. - Age of the patient in between 18-60 years, both the sexes and complaint will be selected randomly from the cases attending in Hospital OPD and Rural OPD.

Exclusion criteria

Exclusion criteria: - The cases in which totality of symptoms will not match with the Indian homoeopathic drugs will be excluded. - Female cases with pregnancy will be excluded. - Cases with the irreversible pathology will be excluded from the study.

Design outcomes

Primary

Measure	Time frame
Modified Naranjo Criteria for Homoeopathy (MONARCH) Scoring SystemTimepoint: At the baseline and at each follow-up	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Aneri Doshi

Dr V H Dave Homoeopathic Medical College and Smt. S I Patel(I) Homoeopathic Hospital, Anand

dr.meerashah@yahoo.com9898692003

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026